Associate Professor, University of Ottawa

Dr. Sarah Kemme is an Assistant Professor in Pediatrics at Monroe Carell Jr. Children's Hospital at Vanderbilt, where she specializes in Pediatric Hepatology and Pediatric Transplant Hepatology. She completed her training at Cincinnati Children's Hospital Medical Center and Children's Hospital Colorado.

Binita was educated at Cambridge University and trained at several London hospitals, including Kings College Hospital. She moved to the Children's Hospital of Philadelphia in 2000 and completed her fellowship in GI, Hepatology and Nutrition. She joined the faculty in 2006 and developed a strong interest in cholestatic liver disease, specifically Alagille syndrome. She joined the faculty at the Hospital for Sick Children, Toronto in 2009 as a Hepatologist and Clinician-Investigator continuing to work on biliary diseases and utilizing stem cell biology to develop disease models.

Dr McLin, FAASLD, is the Medical Director of the Swiss Pediatric Liver Center located in Geneva, Switzerland. She is the Principal Investigator of the International Registry of Congenital Portosystemic Shunts and the chair of the ESPGHAN SIG called IRCPSS. In addition, she has been working in the field of chronic hepatic encephalopathy in children for 15 years. Valérie is an active member of AASLD, ESPGHAN, EASL, ERN RARE LIVER, VALDIG, and GIG.

Margarita German, MD, is a transplant hepatologist and Assistant Professor of Medicine at the University of Wisconsin School of Medicine and Public Health. Her clinical and research interests lie predominantly in optimizing the care of patients with alcohol-associated liver disease (ALD). Dr. German founded a multidisciplinary integrated alcohol-associated liver disease clinic at University of Wisconsin, where hepatologists, addiction medicine specialists, and a social worker are co-located to provide the most comprehensive care for patients with ALD.

Dr. Reena Salgia is a transplant hepatologist and medical director of the Liver Cancer Clinic at Henry Ford Health. She is an Associate Professor of Medicine at Wayne State University and Michigan State University and since 2017 has served as the Program Director for the Gastroenterology and Transplant Hepatology Fellowship Programs at Henry Ford. <br>Her clinical practice focuses on hepatology, transplantation, and hepatocellular carcinoma, as well as liver transplant for HCC and non-HCC considerations.

Frank DiPaola, MD, is an Associate Professor of Pediatrics and the Medical Director of Pediatric Hepatology at University of Virginia. Dr. DiPaola provides care to children with both short-term and long-term liver conditions. He is board-certified in pediatric gastroenterology and pediatric transplant hepatology.

Mitchell R. McGill, PhD, NRCC, FADLM (or just Mitch!) is Associate Professor of Pathology, Toxicology, and Public Health at the University of Arkansas for Medical Sciences. His primary interests are 1) mechanistic and clinical aspects of acetaminophen hepatotoxicity, 2) biomarkers of liver injury for clinical and regulatory applications, and 3) fundamental mechanisms of liver repair.

Dr. Thanapirom is currently a clinical lecturer and consultant hepatologist with a special interest in both basic and clinical research focused on liver fibrosis, cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease, and liver transplantation.